|
US4444879A
(en)
|
1981-01-29 |
1984-04-24 |
Science Research Center, Inc. |
Immunoassay with article having support film and immunological counterpart of analyte
|
|
US4517289A
(en)
|
1982-08-18 |
1985-05-14 |
Brigham And Women's Hospital |
Monoclonal antibodies for human tissue cross-matching
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4921789A
(en)
|
1988-04-20 |
1990-05-01 |
New England Deaconess Hospital Corporation |
Marker for colorectal carcinoma and methods of detecting the same
|
|
US5344760A
(en)
|
1991-06-03 |
1994-09-06 |
Ciba Corning Diagnostics Corp. |
Method of cancer detection
|
|
US5786158A
(en)
|
1992-04-30 |
1998-07-28 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
|
US5790761A
(en)
|
1992-12-11 |
1998-08-04 |
Heseltine; Gary L. |
Method and apparatus for the diagnosis of colorectal cancer
|
|
AU6350894A
(en)
|
1993-03-05 |
1994-09-26 |
Clifford W. Schweinfest |
Colon mucosa gene having down-regulated expression in colon adenomas and adenocarcinomas
|
|
US7229770B1
(en)
|
1998-10-01 |
2007-06-12 |
The Regents Of The University Of California |
YKL-40 as a marker and prognostic indicator for cancers
|
|
DK85193D0
(da)
|
1993-07-16 |
1993-07-16 |
Cancerforskningsfondet Af 1989 |
Suppression of inhibitors
|
|
US6316208B1
(en)
|
1994-01-07 |
2001-11-13 |
Memorial Sloan-Kettering Cancer Center |
Methods for determining isolated p27 protein levels and uses thereof
|
|
EP0854934A4
(en)
|
1995-08-18 |
2000-09-06 |
Donald W Landry |
DETECTION OF ORGANIC COMPOUNDS BY REGULATION OF ANTIBODY CATALYZED REACTIONS
|
|
US5800347A
(en)
|
1995-11-03 |
1998-09-01 |
The General Hospital Corporation |
ROC method for early detection of disease
|
|
NO954667D0
(no)
|
1995-11-17 |
1995-11-17 |
Dagfinn Oegreid |
Fremgangsmåte til deteksjon av Ki-ras mutasjoner
|
|
US5983211A
(en)
|
1996-01-24 |
1999-11-09 |
Heseltine; Gary L. |
Method and apparatus for the diagnosis of colorectal cancer
|
|
US6242212B1
(en)
|
1996-02-09 |
2001-06-05 |
Thomas Jefferson University |
Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
|
|
GB9810040D0
(en)
|
1998-05-11 |
1998-07-08 |
Univ Nottingham |
Blood borne tumour markers
|
|
US6303372B1
(en)
|
1998-06-12 |
2001-10-16 |
Chiron Corporation |
cDNA molecule encoding human CIF130
|
|
GB9827228D0
(en)
|
1998-12-10 |
1999-02-03 |
Univ Nottingham |
Cancer detection method and reagents
|
|
EP1179092A2
(en)
|
1999-01-10 |
2002-02-13 |
Exact Sciences Corporation |
Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
|
|
US7153700B1
(en)
|
1999-03-26 |
2006-12-26 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for diagnosing and predicting the behavior of cancer
|
|
NZ515311A
(en)
|
1999-04-09 |
2002-11-26 |
Rigshospitalet |
Mass screening and highly specific early identification of colorectal or metastatic breast cancer by measuring TIMP-1 tissue inhibitor
|
|
US20010041365A1
(en)
|
2000-01-10 |
2001-11-15 |
Michael Laposata |
Methods for monitoring alcohol consumption
|
|
US6322986B1
(en)
|
2000-01-18 |
2001-11-27 |
Albany Medical College |
Method for colorectal cancer prognosis and treatment selection
|
|
US7301016B2
(en)
|
2000-03-07 |
2007-11-27 |
Millennium Pharmaceuticals, Inc. |
Human transferase family members and uses thereof
|
|
US7577683B2
(en)
|
2000-06-08 |
2009-08-18 |
Ingenuity Systems, Inc. |
Methods for the construction and maintenance of a knowledge representation system
|
|
US6531283B1
(en)
|
2000-06-20 |
2003-03-11 |
Molecular Staging, Inc. |
Protein expression profiling
|
|
AU2001280639A1
(en)
|
2000-07-18 |
2002-01-30 |
Millennium Pharmaceuticals, Inc. |
13237,18480,2245 or 16228 human protein kinase molecules and uses therefor
|
|
US6706506B2
(en)
|
2000-07-24 |
2004-03-16 |
Cornell Research Foundation, Inc. |
Detection of epithelial cell cancers and precancerous conditions
|
|
WO2002074960A2
(en)
|
2000-11-08 |
2002-09-26 |
Millennium Pharmaceuticals, Inc. |
38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
|
|
US7312086B2
(en)
|
2000-12-07 |
2007-12-25 |
Bristol-Myers Squibb Company |
Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
|
|
IL158003A0
(en)
|
2001-03-23 |
2004-03-28 |
Yeda Res & Dev |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer
|
|
CN1526025A
(zh)
|
2001-05-16 |
2004-09-01 |
��˹��ŵ�� |
作为预后和治疗靶标的乳腺癌中表达的基因
|
|
US7031846B2
(en)
|
2001-08-16 |
2006-04-18 |
Affymetrix, Inc. |
Method, system, and computer software for the presentation and storage of analysis results
|
|
DE60239690D1
(de)
|
2001-09-07 |
2011-05-19 |
Univ Johns Hopkins Med |
Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden
|
|
US20040018973A1
(en)
|
2002-01-25 |
2004-01-29 |
University Of Pittsburgh |
Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
|
|
US20030186248A1
(en)
|
2002-03-29 |
2003-10-02 |
Erlander Mark G. |
Interpreting cytological specimens via molecular histological signatures
|
|
EP1367395A1
(de)
|
2002-05-02 |
2003-12-03 |
B.R.A.H.M.S Aktiengesellschaft |
Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern
|
|
WO2003097872A2
(en)
|
2002-05-21 |
2003-11-27 |
Mtm Laboratories Ag |
G - protein coupled receptor marker molecules associated with colorectal lesions
|
|
US20050153382A1
(en)
|
2002-06-06 |
2005-07-14 |
Chengdu Kuachang Science And Technology Co., Ltd. |
Biochip kit comprising biochip based on antigen-antibody reactions, and its usage
|
|
US7425700B2
(en)
|
2003-05-22 |
2008-09-16 |
Stults John T |
Systems and methods for discovery and analysis of markers
|
|
EP3330875B1
(en)
|
2003-07-10 |
2021-12-01 |
Genomic Health, Inc. |
Expression profile algorithm and test for prognosing breast cancer recurrence
|
|
DE102004037860A1
(de)
|
2004-08-04 |
2006-03-16 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
|
|
PT1761779E
(pt)
|
2004-08-13 |
2008-02-01 |
Indivumed Gmbh |
Utilização de transtirretina como um biomarcador de adenoma colorrectal; método de detecção e sistema de teste
|
|
US20060105419A1
(en)
|
2004-08-16 |
2006-05-18 |
Biosite, Inc. |
Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
|
|
WO2006047483A2
(en)
|
2004-10-22 |
2006-05-04 |
Redpath Integrated Pathology, Inc. |
Dynamic genomic deletion expansion and formulation of molecular marker panels for integrated molecular pathology diagnosis and characterization of tissue, cellular fluid, and pure fluid specimens
|
|
WO2006047787A2
(en)
|
2004-10-27 |
2006-05-04 |
Exact Sciences Corporation |
Method for monitoring disease progression or recurrence
|
|
WO2006094149A2
(en)
|
2005-03-01 |
2006-09-08 |
Exact Sciences Corporation |
Methods and compositions for detecting adenoma
|
|
WO2006102526A2
(en)
|
2005-03-22 |
2006-09-28 |
Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Identification of biomarkers by serum protein profiling
|
|
EP1920071B1
(en)
|
2005-07-29 |
2018-12-26 |
Siemens Healthcare Diagnostics Inc. |
Neoplastic disease-related methods, kits, systems and databases
|
|
CN101263391A
(zh)
|
2005-09-12 |
2008-09-10 |
菲诺梅诺米发现公司 |
通过测量维生素e-相关的代谢物诊断结肠直肠癌和卵巢癌的方法
|
|
JP5038311B2
(ja)
|
2005-09-12 |
2012-10-03 |
フェノメノーム ディスカバリーズ インク |
ビタミンｅ関連代謝産物の測定による、結腸直腸癌及び卵巣癌の診断方法
|
|
WO2007036025A1
(en)
|
2005-09-27 |
2007-04-05 |
University Of Saskatchewan |
Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosls
|
|
US7662580B2
(en)
|
2005-11-10 |
2010-02-16 |
Aurelium Biopharma Inc. |
Tissue diagnostics for breast cancer
|
|
GB0524190D0
(en)
|
2005-11-28 |
2006-01-04 |
Helse Stavanger Hf |
Method
|
|
ES2277785B1
(es)
|
2005-12-21 |
2008-06-16 |
Oryzon Genomics, S.A. |
Metodo de analisis de expresion diferencial en cancer colorectal.
|
|
US20090035801A1
(en)
|
2005-12-27 |
2009-02-05 |
Power3 Medical Products, Inc. |
Twelve (12) protein biomarkers for diagnosis and early detection of breast cancer
|
|
EP2412821B1
(en)
|
2006-01-11 |
2014-09-17 |
Genomic Health, Inc. |
AREG as a gene expression marker for colorectal cancer prognosis
|
|
WO2007090125A2
(en)
|
2006-01-30 |
2007-08-09 |
Introgen Therapeutics, Inc. |
Prognostic factors for anti-hyperproliferative disease gene therapy
|
|
WO2007127002A2
(en)
|
2006-03-31 |
2007-11-08 |
Cell Signaling Technology, Inc. |
Protein markers of responsiveness to type iii receptor tyrosine kinase inhibitors
|
|
CA2657691A1
(en)
|
2006-06-19 |
2007-12-27 |
Vanderbilt University |
Methods and compositions for diagnostic and therapeutic targeting of cox-2
|
|
US7811778B2
(en)
|
2006-09-06 |
2010-10-12 |
Vanderbilt University |
Methods of screening for gastrointestinal cancer
|
|
CA2708006A1
(en)
|
2006-12-08 |
2008-06-19 |
The Johns Hopkins University |
Cancer chemoprevention strategy based on loss of imprinting of igf2
|
|
EP2450702A3
(en)
|
2007-01-26 |
2012-07-25 |
University Of Louisville Research Foundation, Inc. |
Methods of detecting autoantibodies for diagnosing and characterizing disorders
|
|
WO2008116178A2
(en)
|
2007-03-21 |
2008-09-25 |
Vanderbilt University |
Systems and methods for diagnosis and prognosis of colorectal cancer
|
|
US8697350B2
(en)
|
2007-06-04 |
2014-04-15 |
Diagnoplex |
Biomarker combinations for colorectal cancer
|
|
US8883440B2
(en)
|
2007-07-26 |
2014-11-11 |
Nancy M. Lee |
Method to predict or diagnose a gastrointestinal disorder or disease
|
|
DE102007034993A1
(de)
|
2007-07-26 |
2009-01-29 |
Hanna Diehl |
Lösliches Cadherin 17 für die Diagnose und Risikostratifizierung von Darmtumor oder Darmkrebs
|
|
WO2009040782A2
(en)
|
2007-09-28 |
2009-04-02 |
Royal College Of Surgeons In Ireland |
A method of assessing colorectal cancer status in an individual
|
|
CN101868729B
(zh)
|
2007-11-20 |
2013-07-17 |
霍夫曼-拉罗奇有限公司 |
利用标记物组合钙防卫蛋白和血红蛋白/触珠蛋白复合物从粪便样品评价结肠直肠癌的方法
|
|
KR101058753B1
(ko)
|
2007-11-22 |
2011-08-24 |
한국생명공학연구원 |
대장암 마커로서의 ｅｓｍ－１ 유전자 및 이를 이용한대장암의 진단 및 치료에의 용도
|
|
JP5591711B2
(ja)
|
2007-12-10 |
2014-09-17 |
エフ．ホフマン−ラ ロシュ アーゲー |
結腸直腸癌のためのマーカーパネル
|
|
DK2223115T3
(da)
|
2007-12-10 |
2011-12-12 |
Hoffmann La Roche |
Seprase som markør for cancer
|
|
EP2249644A4
(en)
|
2008-02-08 |
2012-05-30 |
Poniard Pharmaceuticals Inc |
PICOPLATIN AND AMRUBICIN USEFUL IN THE TREATMENT OF LUNG CANCER
|
|
AU2009213671A1
(en)
|
2008-02-11 |
2009-08-20 |
Hadasit Medical Research Services & Development Limited |
Colon cancer associated transcript 1 (CCAT1) as a cancer marker
|
|
WO2009107170A1
(ja)
|
2008-02-29 |
2009-09-03 |
学校法人日本大学 |
抗ｃｒｐ抗体及びその利用
|
|
EP2255017A1
(en)
|
2008-03-18 |
2010-12-01 |
Epigenomics AG |
A method for optimizing and validating an assay for determining the presence or absence of a medical condition
|
|
EP2259797A2
(en)
|
2008-03-25 |
2010-12-15 |
Schering Corporation |
Methods for treating or preventing colorectal cancer
|
|
EP2868754A1
(en)
|
2008-04-10 |
2015-05-06 |
Genenews Corporation |
Method for determining a probability of colorectal cancer in a subject
|
|
JP2011521215A
(ja)
|
2008-05-14 |
2011-07-21 |
エーテーハー チューリヒ |
前立腺癌の診断及び治療のためのバイオマーカー及び薬剤標的発見法、並びにそれを用いて決定されるバイオマーカーアッセイ
|
|
US8697370B2
(en)
|
2008-05-23 |
2014-04-15 |
Pronota N.V. |
Biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof
|
|
CN102165075A
(zh)
|
2008-07-18 |
2011-08-24 |
奥洁克公司 |
用于检测和治疗结肠直肠癌的组合物
|
|
EP2169077A1
(en)
|
2008-09-19 |
2010-03-31 |
Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg |
Methods and compositions for diagnosing an adenocarcinoma
|
|
US20100204299A1
(en)
|
2009-02-11 |
2010-08-12 |
Daniel Regnier |
C-cbl and antagonists thereof for the treatment and diagnosis of cancer
|
|
EP2398918B1
(en)
|
2009-02-20 |
2018-06-20 |
Onconome, Inc. |
Methods for diagnosis and prognosis of colorectal cancer
|
|
CA2753119A1
(en)
|
2009-02-24 |
2010-09-02 |
F. Hoffmann-La Roche Ag |
Use of s-erbb-3 as a marker for cancer
|
|
AU2010306593B2
(en)
|
2009-10-15 |
2015-09-10 |
Crescendo Bioscience, Inc. |
Biomarkers and methods for measuring and monitoring inflammatory disease activity
|
|
US7736861B1
(en)
|
2009-10-19 |
2010-06-15 |
Aveo Pharmaceuticals, Inc. |
Tivozanib response prediction
|
|
WO2011063232A1
(en)
*
|
2009-11-20 |
2011-05-26 |
University Of Louisville Research Foundation, Inc. |
Biomarkers of cancer
|
|
CA2790416C
(en)
|
2010-03-26 |
2017-05-23 |
Mayo Foundation For Medical Education And Research |
Methods and materials for detecting colorectal neoplasm
|
|
US10119959B2
(en)
|
2010-06-25 |
2018-11-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of assaying an individual for immune impairment
|
|
GB201012590D0
(en)
|
2010-07-27 |
2010-09-08 |
Queen Mary & Westfield College |
Methods for diagnosing cancer
|
|
US8389684B2
(en)
|
2010-09-13 |
2013-03-05 |
Tsinghua University |
Tumor biomarker
|
|
EP2668503B1
(en)
|
2011-01-28 |
2015-06-24 |
F.Hoffmann-La Roche Ag |
Combinatorial biomarkers for clinical applications in lung cancer patient management
|
|
CA2827894A1
(en)
|
2011-02-22 |
2012-08-30 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Circulating biomarkers
|
|
CA2845568A1
(en)
|
2011-08-19 |
2013-02-28 |
Myriad Genetics, Inc. |
Gene signatures for lung cancer prognosis and therapy selection
|
|
WO2013152989A2
(en)
|
2012-04-10 |
2013-10-17 |
Eth Zurich |
Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer
|
|
US20150141273A1
(en)
*
|
2012-04-26 |
2015-05-21 |
Stichting Vu-Vumc |
Biomarkers
|
|
US20140234854A1
(en)
*
|
2012-11-30 |
2014-08-21 |
Applied Proteomics, Inc. |
Method for evaluation of presence of or risk of colon tumors
|